What is Harm Reduction Coalition?
The National Harm Reduction Coalition is a prominent national advocacy and capacity-building organization dedicated to enhancing the health and dignity of individuals and communities affected by drug use. The coalition actively promotes harm reduction policies, practices, and programs designed to mitigate the adverse consequences of drug use, including overdose, HIV, hepatitis C, addiction, and incarceration. Recognizing the profound impact of social inequality and injustice on drug-related harm and the marginalization of vulnerable communities, the organization champions the fundamental right to health and well-being for all individuals, empowering them to participate in public policy dialogues.
How much funding has Harm Reduction Coalition raised?
Harm Reduction Coalition has raised a total of $1.1M across 2 funding rounds:
Unspecified
$750K
Debt
$350K
Unspecified (2019): $750K with participation from CVS Health
Debt (2020): $350K led by PPP
Key Investors in Harm Reduction Coalition
CVS Health
CVS Health is a major healthcare company focused on delivering high-quality, affordable health care and improving the health and well-being of consumers through its extensive reach and integrated health services.
PPP
Public-Private Partnership
What's next for Harm Reduction Coalition?
With a significant infusion of capital, National Harm Reduction Coalition is poised to expand its advocacy efforts and capacity-building initiatives. This major strategic investment will likely fuel the scaling of its programs, enabling broader reach and deeper impact in addressing critical public health issues related to drug use. The organization is expected to further its mission of advancing equitable health policies and supporting communities most affected by drug-related harms, solidifying its position as a leader in the harm reduction space.
See full Harm Reduction Coalition company page
